Analyst Ratings For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Today, Deutsche Bank raised its price target on NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) to $34.00 per share.
Some recent analyst ratings include
- 3/8/2018-Piper Jaffray Reiterated Rating of Hold.
- 1/16/2018-Canaccord Genuity Reiterated Rating of Buy.
- 1/8/2018-Barclays Reiterated Rating of Sell.
- 12/20/2017-William Blair was Downgraded by analysts at William Blair from a “Outperform ” rating to a ” Market Perform” rating.
- 12/13/2017-JPMorgan Chase was Downgraded by analysts at JPMorgan Chase from a “Neutral ” rating to a ” Underweight” rating. They now have a $25.00 price target on the stock.
- 10/20/2017-Jefferies Group Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX) has insider ownership of 46.20% and institutional ownership of 88.93%.
- On 4/16/2018 Kimberly J. Popovits, Insider, sold 15,000 with an average share price of $33.19 per share and the total transaction amounting to $497,850.00.
- On 3/13/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.80 per share and the total transaction amounting to $164,000.00.
- On 2/20/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $32.89 per share and the total transaction amounting to $164,450.00.
- On 2/20/2018 Phillip G Febbo, Insider, sold 4,942 with an average share price of $32.84 per share and the total transaction amounting to $162,295.28.
- On 2/14/2018 Kimberly J Popovits, Insider, sold 10,000 with an average share price of $32.93 per share and the total transaction amounting to $329,300.00.
- On 1/16/2018 Kimberly J. Popovits, Insider, sold 10,000 with an average share price of $34.99 per share and the total transaction amounting to $349,900.00.
- On 1/9/2018 G Bradley Cole, COO, sold 5,000 with an average share price of $35.51 per share and the total transaction amounting to $177,550.00.
Recent Trading Activity for NASDAQ:GHDX – Genomic Health (NASDAQ:GHDX)
Shares of NASDAQ:GHDX – Genomic Health closed the previous trading session at 33.72 up +2.09 6.61% with 34.25 shares trading hands.